Bill · S. 4355· Senate(119-S-4355)
Drug Deal Disclosure Act
- Introduced
- 4/21/2026
- Last activity
- 4/21/2026 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Sponsored by
- Ron Wyden
- Cosponsors
- - 17 - 0
- Introduced
- In Committee
What this bill would do
The Drug Deal Disclosure Act requires the Department of Health and Human Services to release documents and communications regarding private drug pricing deals with manufacturers. These deals include agreements on reduced prices, direct-to-consumer sales, and import duty exemptions. The bill covers specific agreements announced by various pharmaceutical companies and any subsequent new agreements. Information must be made available in a centralized, searchable, and downloadable format. The Secretary is prohibited from withholding information due to political sensitivity or reputational harm. Additionally, the bill mandates economic analysis of these agreements by the CBO and GAO.
Yes· 3 of 10
Does this make what the government does easier for the public to see?+8
The bill requires the public release of records, communications, and contracts related to private drug pricing deals.
Does this lower the price of prescription medicines?+5
The bill increases transparency regarding pricing deals that include reduced drug prices and direct-to-consumer sales.
Would people over 65 be better off under this?+4
Increased transparency in drug pricing agreements may help lower costs for those on Medicare.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Transparency of Drug Pricing: The Secretary must make available all records, documents, communications, and contracts relating to various pricing agreements in a searchable and downloadable format (Section 2(a)(1)).
-
Economic and Budgetary Oversight: The Congressional Budget Office and the Comptroller General are required to publish a report detailing the economic effects of these agreements, including expected direct cost savings for individuals in the United States based on their insurance status (Section 4).
-
Program Impact Analysis: The bill requires a budget analysis regarding the impacts of these agreements on Medicare, Medicaid, and qualified health plans (Section 4(3)).
-
Monitoring Competition and Costs: The required reporting includes an analysis of the impact on drug price competition and health plan formulary design (Section 4(4)).
Potential Negative Impacts for People
-
Redaction of Proprietary Information: The Secretary may withhold or redact specific portions of agreements that contain proprietary pricing information or information protected by other laws (Section 2(c)).
-
Limited Information Access: The Secretary may withhold information that manufacturers are legally prohibited from disclosing based on the laws of other nations or as part of specific settlements or court directives (Section 2(c)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Low Income Households+4Good For Seniors+4Good For Middle Class Households+3
- Healthcare
- Reduces Prescription Drug Costs+5Increases Medicaid Funding+2Increases Medicare Funding+2
- Governance And Ideology
- Improves Government Transparency+8
- Economy And Finance
- Improves Fiscal Responsibility+3
- Social Issues And Justice
- Improves Poverty Reduction+2
- National Security And Foreign Policy
- Improves Veterans Benefits+1
- 4/27/2026
- 1 Cosponsor added.
- 4/21/2026
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 17 Cosponsors added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Tammy BaldwinDemocrat · Wisconsin
Michael BennetDemocrat · Colorado
Maria CantwellDemocrat · Washington
Catherine Cortez MastoDemocrat · Nevada
Ruben GallegoDemocrat · Arizona
Mazie HironoDemocrat · Hawaii
Maggie HassanDemocrat · New Hampshire
Mark KellyDemocrat · Arizona
Ben LujánDemocrat · New Mexico
Jeff MerkleyDemocrat · Oregon
Bernie SandersIndependent · Vermont
Tina SmithDemocrat · Minnesota
Chris Van HollenDemocrat · Maryland
Raphael WarnockDemocrat · Georgia
Peter WelchDemocrat · Vermont
Sheldon WhitehouseDemocrat · Rhode Island
Mark WarnerDemocrat · Virginia
Elizabeth WarrenDemocrat · Massachusetts